← European Medicine Shortage Tracker · all medicines
Epoetin beta currently has availability issues reported in 1 European register: Germany.
Shortage ATC B03XA · also listed as: Epoetin beta · data refreshed 7 August 2026
As of 7 August 2026, 1 of the 10 tracked registers list current availability issues for Epoetin beta, covering 4 affected product presentations. The longest-running open report was filed in Germany on 2025-06-09 and has now been open for about 14 months. Where agencies state a cause, manufacturing problems lead with 4 of the 4 stated-cause reports. The furthest expected-resolution date currently on file is 2027-06-30; the earliest is 2027-06-30. Registers in Germany indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Epoetin beta is coded B03XA — a medicine acting on blood and blood-forming organs — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇩🇪 Germany | Shortage NeoRecormon 2000 IE Injektionslösung in Fertigspritze - OP6 + 3 more productsNeoRecormon 3000 IE Injektionslösung in Fertigspritze - OP6 NeoRecormon 4000 IE Injektionslösung in Fertigspritze - OP6 NeoRecormon 5000 IE Injektionslösung in Fertigspritze - OP6 | 2025-06-09 | 2027-06-30 | Unzureichende Produktionskapazitäten Alternatives: NeoRecormon 2000 IE Injektionslösung in Fertigspritze - OP6 - Einreichungsnummer: 2793868 | register ↗ |
Every individual register entry for Epoetin beta in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇩🇪 DE | NeoRecormon 2000 IE Injektionslösung in Fertigspritze - OP6 | Shortage | 2025-08-04 | 2027-06-30 | Unzureichende Produktionskapazitäten |
| 🇩🇪 DE | NeoRecormon 4000 IE Injektionslösung in Fertigspritze - OP6 | Shortage | 2025-07-21 | 2027-06-30 | Unzureichende Produktionskapazitäten |
| 🇩🇪 DE | NeoRecormon 3000 IE Injektionslösung in Fertigspritze - OP6 | Shortage | 2025-07-07 | 2027-06-30 | Unzureichende Produktionskapazitäten |
| 🇩🇪 DE | NeoRecormon 5000 IE Injektionslösung in Fertigspritze - OP6 | Shortage | 2025-06-09 | 2027-06-30 | Unzureichende Produktionskapazitäten |
Yes. As of 7 August 2026, availability issues are reported in: Germany. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2027-06-30 to 2027-06-30. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
4 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency register that lists Epoetin beta: BfArM (Germany). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Epoetin beta — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/epoetin-beta/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Epoetin beta availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/epoetin-beta/">Epoetin beta shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>